Allosteric modulators in drug development offer which advantages?

• A. They are irreversible activators.
• B. They replace primary orthosteric binding.
• C. They offer greater selectivity and a ceiling effect, potentially limiting toxicity.
• D. They always produce higher efficacy than orthosteric ligands.

Answer: (C)